Ralph H. Hruban

发表

A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts

Young Joon Ahn, Elliot K. Fishman, Yuxuan Wang, 2017, J. Am. Medical Informatics Assoc..

Classification of Pancreatic Cysts in Computed Tomography Images Using a Random Forest and Convolutional Neural Network Ensemble

Joel H. Saltz, Elliot K. Fishman, Arie E. Kaufman, 2017, MICCAI.

A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity

Martin A. Nowak, Bartlomiej Waclaw, Ivana Bozic, 2015, Nature.

Multiscale label-free volumetric holographic histopathology of thick-tissue slides with subcellular resolution

YongKeun Park, Moosung Lee, Ralph H. Hruban, 2021 .

Three-dimensional shape and topology analysis of tissue-cleared tumor samples

Wojciech Zbijewski, Tadashi Yoshizawa, Ralph H. Hruban, 2021, Medical Imaging.

DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

Michael A. Choti, Yuchen Jiao, Victor E. Velculescu, 2011, Science.

DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Scott E. Kern, Stephan A. Hahn, Ralph H. Hruban, 1996, Science.

Allele-specific expression in the germline of patients with familial pancreatic cancer: An unbiased approach to cancer gene discovery

Alison P. Klein, Raimond L. Winslow, Marina Bibikova, 2008, Cancer biology & therapy.

Surgical pathology dissection : an illustrated guide

Ralph H. Hruban, R. Hruban, F. Askin, 1996 .

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Alison P. Klein, Zheng Wang, Manuel Hidalgo, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags

Akhilesh Pandey, Kathleen M. Murphy, Scott E. Kern, 2004, Cancer biology & therapy.

Resected Serous Cystic Neoplasms of the Pancreas: A Review of 158 Patients with Recommendations for Treatment

John L. Cameron, Ralph H. Hruban, Charles J. Yeo, 2007, Journal of Gastrointestinal Surgery.

Exomic Sequencing of Four Rare Central Nervous System Tumor Types

Gary L. Gallia, Yuchen Jiao, Yuxuan Wang, 2013, Oncotarget.

MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias

Michael Goggins, Ralph H. Hruban, Seung-Mo Hong, 2011, Clinical Cancer Research.

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma

Mithat Gönen, Mari Mino-Kenudson, Olca Basturk, 2017, Annals of surgery.

Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer

Ralph H. Hruban, Galen Hostetter, G. Hostetter, 2007, Clinical Cancer Research.

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

Gary L. Gallia, Arthur P. Grollman, Tian-Li Wang, 2013, Proceedings of the National Academy of Sciences.

Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

Alison P. Klein, James R. Eshleman, Giovanni Parmigiani, 2009, Science.

Heterogeneity of Pancreatic Cancer Metastases in a Single Patient Revealed by Quantitative Proteomics*

Akhilesh Pandey, Ralph H. Hruban, Arivusudar Marimuthu, 2014, Molecular & Cellular Proteomics.

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

Scott E. Kern, Ralph H. Hruban, Charles J. Yeo, 2011, Nature.

Genomic Landscapes of Pancreatic Neoplasia

Ralph H. Hruban, L. Wood, R. Hruban, 2015, Journal of pathology and translational medicine.

1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

Michael A. Choti, John L. Cameron, Ralph H. Hruban, 2006, Journal of Gastrointestinal Surgery.

Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer

Manuel Hidalgo, James R. Eshleman, Ralph H. Hruban, 2010, Molecular Cancer Therapeutics.

CT evaluation of thymoma: Spectrum of disease

Ralph H. Hruban, Elliot K. Fishman, Gregory L. Johnson, 1997 .

Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds

Alison P. Klein, Michael Goggins, John L. Cameron, 2004, Cancer Research.

Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors

Elliot K. Fishman, Ralph H. Hruban, Satomi Kawamoto, 2020, Abdominal Radiology.

The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer

Mariza de Andrade, Michael Goggins, Ralph H. Hruban, 2007, Cancer Epidemiology Biomarkers & Prevention.

Pancreaticoduodenectomy (Whipple Resections) in Patients Without Malignancy: Are They All `Chronic Pancreatitis'?

John L. Cameron, Ralph H. Hruban, John K. Boitnott, 2003, The American journal of surgical pathology.

Assessing aneuploidy with repetitive element sequencing

Tian-Li Wang, Rachel Karchin, Robert E. Schoen, 2019, Proceedings of the National Academy of Sciences.